Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Is obesity an outcome of gonadotropin-releasing hormone agonist administration? Analysis of growth and body composition in 110 patients with central precocious puberty.

Palmert MR, Mansfield MJ, Crowley WF Jr, Crigler JF Jr, Crawford JD, Boepple PA.

J Clin Endocrinol Metab. 1999 Dec;84(12):4480-8.

PMID:
10599706
2.

Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.

Boepple PA, Mansfield MJ, Wierman ME, Rudlin CR, Bode HH, Crigler JF Jr, Crawford JD, Crowley WF Jr.

Endocr Rev. 1986 Feb;7(1):24-33. Review.

PMID:
2937629
3.

MANAGEMENT OF ENDOCRINE DISEASE: Long-term outcomes of the treatment of central precocious puberty.

Guaraldi F, Beccuti G, Gori D, Ghizzoni L.

Eur J Endocrinol. 2016 Mar;174(3):R79-87. doi: 10.1530/EJE-15-0590. Review.

4.

Gonadotropin releasing hormone agonist treatment to increase final stature in children with precocious puberty: a meta-analysis.

Li P, Li Y, Yang CL.

Medicine (Baltimore). 2014 Dec;93(27):e260. doi: 10.1097/MD.0000000000000260. Review.

5.

Review of outcomes after cessation of gonadotropin-releasing hormone agonist treatment of girls with precocious puberty.

Thornton P, Silverman LA, Geffner ME, Neely EK, Gould E, Danoff TM.

Pediatr Endocrinol Rev. 2014 Mar;11(3):306-17. Review.

PMID:
24719967
6.

Benefit of postponing normal puberty for improving final height.

Wit JM, Balen HV, Kamp GA, Oostdijk W.

Eur J Endocrinol. 2004 Aug;151 Suppl 1:S41-5. Review.

7.

Pros and cons of GnRHa treatment for early puberty in girls.

Willemsen RH, Elleri D, Williams RM, Ong KK, Dunger DB.

Nat Rev Endocrinol. 2014 Jun;10(6):352-63. doi: 10.1038/nrendo.2014.40. Review.

PMID:
24709660
8.

The use of GnRH agonists in precocious puberty.

Mul D, Hughes IA.

Eur J Endocrinol. 2008 Dec;159 Suppl 1:S3-8. doi: 10.1530/EJE-08-0814. Review.

9.

Gonadotropin-Releasing Hormone Agonist Treatment in Sexual Precocity.

Pienkowski C, Tauber M.

Endocr Dev. 2016;29:214-29. doi: 10.1159/000438893. Review.

PMID:
26680581
10.

Experience with the Histrelin Implant in Pediatric Patients.

Eugster EA.

Endocr Dev. 2016;30:54-9. doi: 10.1159/000439330. Review.

PMID:
26683629
Items per page

Supplemental Content

Support Center